NLRP3 and Alzheimer disease: Following with these important findings, more articles have demonstrated that inhibition of the NLRP3 inflammasome pathway enhanced the clearance of Aβ by upregulating the levels of neprilysin or by shifting microglia to the anti-inflammatory [10, 11] M2 phenotype in AD models.